• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION PERCUFLEX PLUS SUREDRIVE; STENT, URETERAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION PERCUFLEX PLUS SUREDRIVE; STENT, URETERAL Back to Search Results
Model Number UNK-P-PERCUFLEX_PLUS
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Discomfort (2330); Dysuria (2684)
Event Date 07/15/2021
Event Type  Injury  
Manufacturer Narrative
The complainant was unable to provide the suspect device upn and lot number; therefore, the lot expiration and device manufacture dates are unknown.Study: u0652 double-j registry clinical study.(b)(4).
 
Event Description
Note: this report is one of two complaints that pertain to the same event (mfr report #3005099803-2022-0734 and mfr.Report #3005099803-2022-07342).It was reported to boston scientific corporation that a percuflex plus ureteral stents were used in a stent placement procedure for benign obstruction in the right ureter performed on (b)(6) 2021, as part of the u0652 double-j registry clinical study.During the procedure, two percuflex plus ureteral stents were implanted retrograde under fluoroscopy.The stents were successfully implanted.The procedure was performed without any complications.Discharge medications included alpha blocker and narcotic analgesics (opioids).On (b)(6) 2021, a planned stent removal procedure was performed.Pain control was not required.Stents were not difficult to remove and were successfully removed at this attempt.It was reported that the patient had experienced mild stent colic and mild dysuria while the stent was still implanted in the patient for 24 days.The patient was prescribed with tylenol and codeine as treatment for dysuria.The adverse events were reported to have been resolved on (b)(6) 2021.In the physician's assessment, the relationship between the procedure, the device and the event is possibly related.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCUFLEX PLUS SUREDRIVE
Type of Device
STENT, URETERAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
2546 calle primera
alajuela
CS  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key15978930
MDR Text Key305445988
Report Number3005099803-2022-07341
Device Sequence Number1
Product Code FAD
Combination Product (y/n)N
Reporter Country CodeCA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 12/14/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNK-P-PERCUFLEX_PLUS
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/21/2022
Initial Date FDA Received12/14/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age63 YR
Patient SexFemale
-
-